Skip to main content
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. — Investor Relations & Filings

Ticker · PCRX ISIN · US6951271005 LEI · 549300P56LERYBDHCF69 US Manufacturing
Filings indexed 1,216 across all filing types
Latest filing 2024-07-30 Interim / Quarterly Rep…
Country US United States of America
Listing US PCRX

About Pacira BioSciences, Inc.

https://www.pacira.com/

Pacira BioSciences, Inc. is a pharmaceutical company that develops, commercializes, and manufactures non-opioid pain management and regenerative health solutions. The company's mission is to provide alternatives to opioids by delivering innovative, precise, and targeted therapies. Its products and research pipeline address a diverse range of needs, including postsurgical, chronic, and musculoskeletal pain. Pacira is also focused on developing advanced solutions, including gene therapy, to address unmet needs in pain management.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2024
2024-07-30 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 30, 2024, by Pacira BioSciences, Inc. It announces the issuance of a press release containing financial results for the second quarter ended June 30, 2024. The document explicitly states that the press release is furnished as an exhibit and is not deemed filed for certain regulatory purposes. The text is relatively short (3385 characters) and primarily serves as an announcement of the earnings release rather than containing the financial results itself. According to the 'Menu vs Meal' rule, this is an announcement of a report (the earnings press release) rather than the report itself. Therefore, the appropriate classification is Earnings Release (ER), as the document includes the earnings press release as an exhibit and announces quarterly financial results.
2024-07-30 English
FORM 4
Director's Dealing
2024-07-04 English
FORM 4
Director's Dealing
2024-07-04 English
Regulatory Filings 2024
Regulatory Filings
2024-07-02 English
FORM 4
Director's Dealing
2024-06-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.